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ABSTRACT 
Aim: The aim of this study was to explore the quality of life (QoL) in a group of patients who had an intractable disease on medical 
therapy including biologics and underwent surgery. 
Background: Quality of life of patients with ulcerative colitis (UC) has been measured with a series of multiple questionnaires  
Methods: An observational cross sectional study was carried out on 68 patients with documented UC referring to an IBD clinic in a 
tertiary hospital. Patients with UC who had a colectomy because of intractable disease and were in remission for a year were eligible 
for enrollment Patients were instructed to fill the SF-36 Questionnaire (interviewer-administered) regarding quality of life. Side 
effects were evaluated with another questionnaire. Results were compared with the normal population of the community.  
Results: In comparison with normal population, patients having colectomy have better general QoL. Impotency and incontinency 
were most common adverse events after colectomy while the adverse events that decreased the QoL significantly were anal secretions 
and number of bowel movements per day without using antidiarrheal- drugs.  
Conclusion: In conclusion, our study showed a significant improvement of general QoL in a selected group of UC patients, who were 
in clinical remission following IPAA and only number of bowel movements per day and anal secretions significantly impaired their 
QoL. We suggest that a disease-specific questionnaire should be designed, making changes in health-related QOL more detectable 
over time, since it is more sensitive to these changes in IBD patients than a general questionnaire. 
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Introduction  
  1 Treatment of ulcerative colitis (UC) relies on 
modifying immune system and done by a step-up 
approach according to the severity and the spread of 
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disease, which starting with 5-ASA drugs in milder 
and more limited disease to adding corticosteroids, 
immunomodulators and biologic drugs in more severe 
and extensive type. Colectomy would be carried out in 
intractable cases and emergencies (1-2). Although 
medical therapy is the basis of UC treatment, surgical 
management still have an important role since it can be 
an option for cases that are resistant to medical 
treatment, premalignant or malignant lesions and even 
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be lifesaving in emergent cases (3,4).  In comparison to 
the past, the role of surgeries has changed from 
decreasing mortality to become an option for reducing 
morbidity and especially improving quality of life 
(QoL) (5).  Most of the UC patients, experience some 
degrees of impairment in health-related quality of life 
(HRQL) compared to the general population (6). One 
of the essential aspects of treatment in these patients is 
evaluation of QoL and disability assessments 
associated with medical or surgical therapies. The 
World Health Organization’s definition for quality of 
QoL is “the perception of the individual of his/her 
position in life in the cultural context and the value 
system in which he/she lives in relation to his/her 
objectives, expectations, standards, and concerns” (7). 
Recently the QoL of these patients has been measured 
with a series of multiple questionnaires based on 
psychological and physical function, with a standard 
and quantitative procedure (6). The aim of this study 
was to explore QoL in a group of patients who had an 
intractable disease on medical therapy including 
biologics and underwent surgery.   
 
Methods 
An observational cross sectional study was carried 
out on 68 adult patients (95% reliability and d=80%) 
with documented UC were consecutively recruited 
from a tertiary center. Patients were identified by 
retrospective chart review. All patients with UC who 
had a colectomy because of intractable disease and 
were in remission for a year, were eligible for 
enrollment. All of them had pouch reconstruction and 
patients with a (sub)total colectomy or ostomy were 
excluded. We chose patients in remission in order to 
evaluate their QoL, since those who are not in 
remission will surely have a low QoL.  
Patients were instructed to fill the Short Form-36 
Questionnaire (interviewer-administered) regarding 
QoL.  This questionnaire was translated in Persian and 
validated. Medical feedbacks based on SF-36 
Questionnaire which contains 36 questions and 8 
different invoice reviews was a general approach that 
has been used for measurement of the life quality in 
different populations and patients. It includes pain, 
general health, mental health, physical function, mental 
function, and the role of emotions and physical power. 
Each scale has been rated by number of items: Physical 
functioning, Role limitations due to physical health, 
Role limitations due to emotional problems, 
Energy/fatigue, Emotional well-being, Social 
functioning, Pain and General health are recorded by 
10, 4, 3, 4, 5, 2, 2 and 5 items respectively. On the 
other hand, two prime fields have been followed by 
SF-36 questionnaire, including mental (according to 
the emotional and mental items scoring 0-100) and 
physical (regarding to the functional system rating 0-
50) QoL. This questionnaire has been graded from 0 to 
100. A higher score shows better QoL. We also 
evaluate the types and frequency of adverse events 
after surgery. All surgeries were performed by two 
surgeons with one technique. This study was approved 
by Shahid Beheshti University of Medical Sciences 
ethics committee and written informed consent was 
obtained from each participant. 
The Student’s t-test was used for comparisons of 
variable. SPSS statistical software version 19 (SPSS 
INC, Chicago, IL, United States) was used to perform 
statistical analysis. P < 0.05 was considered 
statistically significant. Continuous variables are 
expressed as means and standard deviation, and 95% 
CI as appropriate.  
 
Results 
Data collection and Subject characteristics 
79 patients with UC were eligible for this study, of 
which were willing sixty eight to participate and 
therefore, enrolled in our study. All patients were 
outpatients. Each questionnaire was filled out 
completely by 100% of patients. Baseline characteristics 
are shown in Table 1.  
 
Table 1. Demographic characteristics of patients included. 
Results are expressed in means±SD and (%). 
 Baseline characteristics 
Age (Mean ± SD) 
Age at Diagnosis (mean±SD) 
Age at colectomy (Mean ± SD) 
39.26±11.08 
29.71 ± 10.208 
37.55 ± 11.176 
Gender  
male 37(56.9%) 
female 28(43.1%) 
BMI (kg/m2)  
under weight 8(12.3%) 
normal 35(53.8%) 
over weight 16(24.6%) 
Obese 
Married 
6(9.2%) 
47(72 %) 
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Table 2. The Quality of life scoring in colectomy patients, 
consisting of general, physical and mental QoL evaluation. The 
results are presented in means±SD and SF-36 values 
QoL Variables  
General QoL Mean ±SD  
Range 
86.73±13.89 
44-100 
Physical QoL Mean ±SD  
Range 
30.83±6.50 
10-39 
Mental QoL Mean±SD  
Range 
36.74±10.48 
18-90 
 
Table 3. Pearson correlation coefficient of bowel movements 
per day and quality of life in Ulcerative Colitis patients who 
have undergone colectomy 
 Pearson correlation coefficient P-value 
General QOL -0.240 0.044 
Physical QOL -0.222 0.060 
Mental QOL -0.342 0.004 
 
Effects of colectomy on patients’ QoL with previous 
intractable disease 
According to SF-36 questionnaire values, general, 
mental, and physical aspects of QoL, the scores have 
been calculated in all patients.  In Comparison to normal 
population colectomy patients have better general Qol 
but lower physical and mentally related QoL. 
Analysis of each entity of SF 36- questionnaire 
The questionnaire including six separate entities; 
General health: Rating the patients’ health in general 
compared to one year ago, limitation of activities during 
a typical day, physical health problems, emotional health 
problems, energy and emotions and social activities 
which data are shown in supplementary tables 1-8.  
Frequency of adverse events after colectomy 
A significant association was observed between the 
number of defecation according to the following 
categories: less than one time=2.9%; 1-3 times=11.7%; 
3-6 times =38.2% and more than 6 times per day=42% 
(p value: 0.043). 
 
Discussion 
This study evaluated the QoL in patients who 
underwent colectomy because of intractable disease 
and were in remission phase during a past year. In the 
vast majority of other studies, the improvement of the 
QoL is defined as a statistically significant increase in 
the scoring of the questionnaires, but present 
evaluation gives an answer to part of daily life that is 
more affected by colectomy. Mostly, mean score of 
general QoL in UC patients after colectomy is higher 
than Iranian general population but with focusing on 
each section (mentally and physically) separately, 
mean score is lower in UC patients (8). The 
justification for this can be that patients had severe and 
intractable illness before surgery and large part of their 
problems disappear with surgery including the 
systemic inflammation, abdominal pain and bleeding. 
So general QoL is much better than a healthy 
individual who spend his/her monotonous life but 
actually in detail cannot ignore the basic physical and 
mental problems. There is no exact data to compare 
these scores with Iranian UC patients on Anti TNF. 
Compare to international statistics of colectomy: 
Perceived and actual QoL among patients with mild, 
moderate, and severe UC were compare by Waljee et 
al; patients who had undergone colectomy for UC; and 
a control group of healthy patients. UC patients 
without colectomy had a significantly higher median 
utility than post-colectomy patients. Those who had 
undergone colectomy viewed the scenario describing 
 
Table 4. Relation between nocturnal defecation, stool incontinency, and anal secretions with quality of life in ulcerative colitis 
patients whom undergone colectomy 
 Nocturnal defecation 
Number       Mean±SD       P-value 
Stool incontinency 
Number    Mean±SD        P-value 
Anal secretions 
Number            Mean±SD     P-value 
General QOL 21/70 86.48±11.84 0.733 26/70 88.27±9.31 0.171 12/70 81.42±10.79 0.0169 
Mental QOL 21/70 37.14±8.53 0.836 26/70 37.19±7.88 0.785 12/70 39.08±16.71 0.400 
Physical QOL 21/70 31.38±6.65 0.824 26/70 32.61±5.97 0.138 12/70 27.00±5.97 0.015 
 
Table 5. Relation between enuresis and urinary hesitancy with quality of life in ulcerative colitis patients whom undergone colectomy 
 Enuresis 
Number       Mean±SD           P-value 
Urinary hesitancy 
Number            Mean±SD           P-value 
General QOL 9/70 82.33±10.18 0.363 13/70 84.46±9.12 0.674 
Mental QOL 9/70 34.55±5.80 0.507 13/70 39.15±16.90 0.362 
Physical QOL 9/70 28.66±6.54 0.228 13/70 31.54±4.70 0.796 
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life with moderate UC significantly less favorable than 
UC patients on medical therapy (9). Fazio et al showed a 
good QoL in 93% of their 645 patients studied for 40 
months after colectomy and they concluded that the 
presence of a temporary ileostomy did not seem to 
influence the QoL (10). 
In addition, each part of questionnaire analyzed with 
more details to asses which aspects of QoL including 
General health: Rating the patients’ health in general 
compared to one year ago, limitation of activities during 
a typical day, physical health problems, emotional health 
problems, energy and emotions and social activities that 
in comparison with Iranian general population  
emotional role functioning ,social role functioning and 
mental health problems was significantly different 
between two groups in favor of colectomy patients. 
Impotency and incontinency were most common 
adverse events after colectomy while the adverse- events 
that decreased the QoL significantly were anal 
secretions and number of bowel movements per day 
without using of antidiarrheal- drugs such as 
Loperamide. 
A population-based cohort on Norwegian IBD patients 
found lower SF-36 scores for almost every dimension in 
the IBD group compared with healthy participants. The 
main differences were related to general, physical, and 
emotional health. They also found a relation between 
severity of IBD and health-related QoL, were general 
health, bodily pain, and role-physical dimensions were 
most affected (7). Casellas et al. revealed significantly 
lower scores in all dimensions in active IBD patients in 
contrast with those in remission. Disease activity, time 
of evolution since diagnosis, and female sex had a worse 
health-related QoL. The type of IBD or geographical 
area of residence did not influence QoL (6). A placebo-
controlled double blinded study evaluated the impact of 
infliximab on health-related QoL in UC patients. They 
concluded that a sustained significant benefit till a year 
was seen in patients with UC on maintenance infliximab 
(11). Another population-based study in Swedish 
patients with IBD showed that patients with UC had a 
higher level of health-related and disease-specific QoL 
compared with patients with Crohn’s disease. An 
ileostomy did not seem to affect their patients’ QoL, but 
an ileoanal anastomosis did by reducing it (12). Heikens 
and Francone et al. reported increased and almost 
normal QoL in patients undergoing ileal pouch anal 
anastomosis (13,14). 
The QoL in patients with severe UC after total 
colectomy versus cyclosporine was compared by Cohen 
et al. The latter group reported a better stool consistency, 
better sleep, less abdominal and rectal pain, and less 
trips to the toilet (15). Early IPAA in severe UC reduced 
health costs and had an equivalent QoL compared to 
 
Figure 1. The percentage of adverse events after colectomy including impotence and retrograde which are evaluated in male; 
night defecation; incontinence; pouchitis; anal pain; abdominal pain; leakage; fistula; nucturia  and the frequent defecation. 
*, ** The percentage of impotence and retrograde have been calculated in patients underwent colectomy; *** Diagnosis of pouchitis was based 
on occurrence of certain symptoms in combination with endoscopic findings. 
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extensive medical therapy (16). Van der Valk et al. 
conducted a large cohort from the COIN study and their 
results revealed that health care costs were mainly due to 
medications, whereas hospitalization and surgery were 
minorities (17). 
In conclusion, our study showed a significant 
improvement of general QoL in a selected group of UC 
patients, who were in clinical remission following IPAA 
and only number of bowel movements per day and anal 
secretions were significantly impaired their QoL. 
Our study had limitations including a retrospective 
design. Retrospective designs make way for prospective 
designs such as cohorts, as they are relatively 
inexpensive and time consuming. Regarding, the timing 
of the study after treatment protocols, since all patients 
in both groups were in complete remission, we believe 
this should not be an important confounding factor. 
We suggest that a disease-specific questionnaire should 
be designed, making changes in health-related QoL 
more detectable over time, since it is more sensitive to 
these changes in IBD patients than a general 
questionnaire. It should be emphasized that using both a 
disease-specific and general QoL questionnaire could 
fill the pitfalls of each other. 
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